Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertoni

Showing results (131-140 of 325) with videos related to

Pageof 33
Sort By:
Oncotarget|February 12, 2015
Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitorLoredana Vesci, Elena Bernasconi, Ferdinando Maria Milazzo, et al.
Journal of Molecular Endocrinology|April 20, 2011
Anaplastic lymphoma kinase in human cancerAntonella Barreca, Elena Lasorsa, Ludovica Riera, et al.
Oncotarget|November 28, 2014
Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphomaRosaria Chilà, Alessandra Basana, Monica Lupi, et al.
Hematological Oncology|March 5, 2025
Targeting of PIM Kinases Shows Single Agent Efficacy and Synergizes With BCL2 Inhibitors in Diffuse Large B Cell Lymphoma of the ABC SubtypeChiara Tarantelli, Omar Kayali, Elisa Civanelli, et al.
Oncology (Williston Park, N.Y.)|April 12, 2012
Splenic marginal zone lymphoma: current knowledge and future directionsCatherine Thieblemont, Frederic Davi, Maria-Elena Noguera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2005
Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapyGiovanni Martinelli, Daniele Laszlo, Andrés J M Ferreri, et al.
British Journal of Haematology|December 18, 2012
Gains of CCND3 gene in ocular adnexal MALT lymphomas: an integrated analysisZhi-Ming Li, Lorenzo Spagnuolo, Afua A Mensah, et al.
American Journal of Cancer Research|June 9, 2023
The microtubule-targeted agent lisavanbulin (BAL101553) shows anti-tumor activity in lymphoma modelsFilippo Spriano, Luca Aresu, Luciano Cascione, et al.
British Journal of Haematology|November 29, 2011
Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single arrayIvo Kwee, Andrea Rinaldi, Paola Rancoita, et al.
British Journal of Haematology|August 4, 2015
The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical modelsElena Bernasconi, Eugenio Gaudio, Ivo Kwee, et al.
Pageof 33

Showing results (131-140 of 325) with videos related to

Sort By:
Pageof 33
Oncotarget|February 12, 2015
Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitorLoredana Vesci, Elena Bernasconi, Ferdinando Maria Milazzo, et al.
Journal of Molecular Endocrinology|April 20, 2011
Anaplastic lymphoma kinase in human cancerAntonella Barreca, Elena Lasorsa, Ludovica Riera, et al.
Oncotarget|November 28, 2014
Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphomaRosaria Chilà, Alessandra Basana, Monica Lupi, et al.
Hematological Oncology|March 5, 2025
Targeting of PIM Kinases Shows Single Agent Efficacy and Synergizes With BCL2 Inhibitors in Diffuse Large B Cell Lymphoma of the ABC SubtypeChiara Tarantelli, Omar Kayali, Elisa Civanelli, et al.
Oncology (Williston Park, N.Y.)|April 12, 2012
Splenic marginal zone lymphoma: current knowledge and future directionsCatherine Thieblemont, Frederic Davi, Maria-Elena Noguera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2005
Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapyGiovanni Martinelli, Daniele Laszlo, Andrés J M Ferreri, et al.
British Journal of Haematology|December 18, 2012
Gains of CCND3 gene in ocular adnexal MALT lymphomas: an integrated analysisZhi-Ming Li, Lorenzo Spagnuolo, Afua A Mensah, et al.
American Journal of Cancer Research|June 9, 2023
The microtubule-targeted agent lisavanbulin (BAL101553) shows anti-tumor activity in lymphoma modelsFilippo Spriano, Luca Aresu, Luciano Cascione, et al.
British Journal of Haematology|November 29, 2011
Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single arrayIvo Kwee, Andrea Rinaldi, Paola Rancoita, et al.
British Journal of Haematology|August 4, 2015
The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical modelsElena Bernasconi, Eugenio Gaudio, Ivo Kwee, et al.
Pageof 33